Melphalan Study guides, Class notes & Summaries
Looking for the best study guides, study notes and summaries about Melphalan? On this page you'll find 113 study documents about Melphalan.
Page 3 out of 113 results
Sort by
-
BMTCN questions and answers
- Exam (elaborations) • 6 pages • 2024
-
Available in package deal
-
- $7.99
- + learn more
What type of transplants commonly have PTLD as a secondary malignancy? - 
ANSWER-Allo HSCT with T-cell depleted graft 
Therapies associated with therapy-related acute leukemia and MDS - 
ANSWER-alkylating agents (eg. Cytoxan, cisplatin, melphalan, busulfan, ifos) , 
radiation, topoisomerase II inhibitors (eg. doxorubicin, etoposide, mitoxantrone) 
Genetic predispositions that increase risk of primary and secondary cancers - 
ANSWER-neurofibromatosis type 1, Fanconi anemia 
Risk factors for PTLD ...
-
BMTCN TEST A WITH 100% CORRECT ANSWERS
- Exam (elaborations) • 14 pages • 2023
-
Available in package deal
-
- $14.49
- + learn more
Immunoglobulins are secreted by which type of cell? 
 
A. B-lymphocyte 
B. Megakaryocyte 
C. T-lymphocyte 
D. Natural killer 
A. B-lymphocyte 
 
B lymphocytes synthesize and secrete immunoglobulins. 
 
 
 
Which portion of the immunoglobulin activates the complement pathway? 
 
A. MHC Class I 
B. Fab 
C. Fc 
D. MHC Class II 
C. Fc 
 
The Fc region activates the complement pathway. 
 
 
 
Which of the following is a class II HLA antigen? 
 
A. B 
B. DR 
C. A 
D. C 
B. DR 
 
HLA DR, DQ and DP are ...
-
Oncology Certification – Chemo Test Questions with Answers
- Exam (elaborations) • 3 pages • 2024
-
Available in package deal
-
- $9.49
- + learn more
vesicants bleomycin, carmustine, cisplatin, daunorubicin, doxorubicin, etposide, idarubicin, melphalan, taxol, vincristine 
 
cisplatin antidote sodium thiosulfate 
 
doxorubicin antidote Dexrazoxane 
 
vincristine antidote hyaluronidase 
 
Alkylating agents busulfan, cytoxan, melphalan, ifosfamide, carmustine; cell cycle non-specific; affects heme, GI, reproductive 
 
antimetabolites methotrexate, 5-FU, cytarabine, gemcitabine, fludarabine; cell cycle specific, affect counts & GI 
 
platinum co...
-
Chemotherapy Questions With Complete Solutions
- Exam (elaborations) • 14 pages • 2023
-
Available in package deal
-
- $10.49
- + learn more
What do alkylating agents do? correct answer: Active throughout cell cycle. Causes breaks in DNA helix, preventing replication and transcription of RNA. 
 
What are the alkylating agent drugs? correct answer: Bendamustine (Treanda) 
Busulfan (Myleron) 
Carboplatin (Paraplatin) 
Carmustine (BCNU) 
Chlorambucil (Leukeran) 
Cisplatin (Platinol, CDDP) 
Cyclophosphamide (Cytoxan, CTX) 
Dacarbazine (DTIC) 
Ifosfamide (Iflex) 
Mechlorethamine (Nitrogen Mustard) 
Melphalan (Alkeran) 
Oxaliplatin (Elo...
-
ONS fundamentals Exam Questions and Answers 100% Pass
- Exam (elaborations) • 5 pages • 2024
- Available in package deal
-
- $11.49
- + learn more
ONS fundamentals Exam Questions and 
Answers 100% Pass 
when chemo is used before primary treatment (surgery) to reduce the size of a tumor - 
Correct Answer ️️ -neoadjuvant therapy 
neoadjuvant therapy is common for what 2 kind of cancers? - Correct Answer ️️ -colon 
and breast 
when chemo is used after primary (surgery, radiation) - Correct Answer ️️ -adjuvant 
induction - Correct Answer ️️ -start of chemo 
consolidation - Correct Answer ️️ -testing labs and such after chem...
Fear of missing out? Then don’t!
-
BMTCN questions with multiple correct answers
- Exam (elaborations) • 6 pages • 2024
- Available in package deal
-
- $7.99
- + learn more
What type of transplants commonly have PTLD as a secondary malignancy? - 
ANSWER-Allo HSCT with T-cell depleted graft 
Therapies associated with therapy-related acute leukemia and MDS - 
ANSWER-alkylating agents (eg. Cytoxan, cisplatin, melphalan, busulfan, ifos) , 
radiation, topoisomerase II inhibitors (eg. doxorubicin, etoposide, mitoxantrone) 
Genetic predispositions that increase risk of primary and secondary cancers - 
ANSWER-neurofibromatosis type 1, Fanconi anemia 
Risk factors for PTLD ...
-
Plasma Cell Leukemia – Facts and Controversies: More Questions than Answers?
- Exam (elaborations) • 10 pages • 2024
-
- $14.49
- + learn more
3.2.2. New agents 
Immunomodulatory drugs (IMIDs) and proteasome inhibitors 
(PIs), now widely used in antimyeloma therapy, have significantly 
improved survival of MM patients [33,34]. There is an increasing 
evidence in the literature that these agents may also improve the outcome in pPCL, but the benefit is less apparent when compared with 
MM. Bortezomib is probably the key new agent in pPCL, and, when 
used in drug combination, rapidly reduces tumor load and reverses 
complications s...
-
BMTCN TEST B ACTUAL QUESTIONS AND ANSWERS 2024 GRADED A+
- Exam (elaborations) • 18 pages • 2024
- Available in package deal
-
- $12.99
- + learn more
BMTCN TEST B ACTUAL QUESTIONS AND ANSWERS 2024 GRADED A+ 
Transplant-related toxicity is a barrier that contributes to the under utilization for which of the following diseases? 
 
A. Non-Hodgkin lymphoma 
B. Acute myeloid leukemia 
C. Sickle cell disease 
D. Neuroblastoma Ans- C. Sickle cell disease 
 
Despite success of HSCT in sickle cell disease, barriers to successful HSCT include lack of a suitable donor, transplant related toxicity and immunologic graft rejection. 
 
Which of the foll...
-
BMTCN Chapter 4: Transplant Preparative Regimens, Cellular Infusion, Acute Complications, and Engraftment 2023/2024 updated to pass
- Exam (elaborations) • 3 pages • 2023
- Available in package deal
-
- $9.99
- + learn more
BMTCN Chapter 4: Transplant Preparative Regimens, Cellular Infusion, Acute Complications, and EngraftmentWhat is the most important rationale for giving total body irradiation in multiple fractions? 
A. It is easier for patients. 
B. It decreases short-term side effects. 
C. It decreases long-term side effects. 
D. It is easier for radiation staff. - correct answer C. It decreases long-term side effects. 
 
What change can decrease side effects of busulfan? 
A. Using oral busulfan 
B. Basing the...
-
BMTCN ch.04(questions with verified solutions)2023/2024 updated to pass
- Exam (elaborations) • 3 pages • 2023
- Available in package deal
-
- $9.99
- + learn more
BMTCN ch.04 
preparative regimens - correct answer aka conditioning regiment 
part of HSCT when tx malignant diseases 
goal: eradicate residual disease and/or provide immunosuppression to prevent graft rejection 
prepare receipients bone marrow to accept new donor cells 
 
examples of chemo - correct answer cyclophosphamide 
busulfan 
etoposide 
cytarabine 
carmustine 
melphalan 
 
myeloablative regimens - correct answer lethal doses of chemo (usually includes alkylating agents) with or without ...
Do you wonder why so many students wear nice clothes, have money to spare and enjoy tons of free time? Well, they sell on Stuvia! Imagine your study notes being downloaded a dozen times for $15 each. Every. Single. Day. Discover all about earning on Stuvia